# Tianjin MNCHIP Technologies Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/tianjin-mnchip-technologies-co

- Industry: Medical Devices & Equipment
- Headquarters: Tianjin, China
- Website: www.mnchip.com/
- Total disclosed funding: $2.2M
- Latest round: Series B (Jul 6, 2018)
- Investors on record: 5

## About

Founded in 2010 and based in Tianjin, China, Tianjin MNCHIP Technologies Co., Ltd, trading under the name MNChip, focuses on developing rapid and precise in-vitro diagnostic solutions. The company applies microfluidic technology to simplify complex biochemical testing and expand access to reliable diagnostic tools. MNChip’s product lines, Celercare and Pointcare, are now used by healthcare and veterinary institutions in over 20 countries. As of 2022, MNChip had supplied more than 20,000 devices worldwide. In November 2023, the firm closed a round of venture funding from China Merchants Capital and Fortune Capital.

The company's main products include fully automatic biochemical analyzers designed for clinical and veterinary diagnostics. Its Celercare and Pointcare series are based on microfluidic technology, requiring minimal blood samples and providing rapid, comprehensive results.

The company generates revenue primarily through the sale of diagnostic analyzers and related consumables to hospitals, laboratories, and veterinary clinics. The company also provides after-sales support, calibration and maintenance services to its clients.

MNChip aims to broaden its international market reach and expand its product portfolio by launching new immunoassay and hematology analyzers. The company also plans to enhance its R&D capacity in microfluidic diagnostics to further support accessible and cost-effective testing solutions globally.

## Funding rounds

- Series B, Jul 6, 2018 — Legend Capital, Fortune Capital, Suzhou TechWisdom Capital
- Series A, Jan 6, 2015 — Legend Capital, Legend Holdings
- Angel, Jun 1, 2010, $2.2M — Legend Star

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Angel
- Legend Capital — Series A, Series B
- Legend Holdings — Series A
- Fortune Capital — Series B
- Suzhou TechWisdom Capital — Series B